News
Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock
Amy Bachrodt, SVP, Finance of Maze Therapeutics (NASDAQ:MAZE), exercised 5,000 options and immediately sold the underlying common shares on Jan. 22, 2026, for a total transaction value of
1 Vanguard Index Fund Could Turn $500 Per Month Into a $986,900 Portfolio That Pays $15,700 in Annual Dividend Income
The median annual income for full-time workers aged 25 to 34 was $59,800 during the third quarter, according to the Bureau of Labor Statistics. That means after-tax earnings would be about $45,400
Best Consumer Stock to Buy Right Now: Costco or Walmart?
Walmart (NASDAQ: WMT) operates big box stores, grocery stores, and membership-based club stores. Costco (NASDAQ: COST) only runs club stores. That said, both are gigantic retailers, claiming the top
Wall Street Has a Federal Reserve Problem, With a Perfect Storm Brewing in 2026
For much of the last seven years, optimists have ruled the roost on Wall Street. The benchmark S&P 500 (SNPINDEX: ^GSPC) has had only three periods since 1928 where it's rallied at least 16%
Beam Therapeutics Senior Vice President Sells 6,198 Shares for $216,933
Bethany J. Cavanagh, SVP, Finance and Treasurer of Beam Therapeutics (NASDAQ:BEAM), executed an open-market sale of 6,198 shares valued at approximately $216,933 on Jan. 22, 2026, as disclosed in a
3 Vanguard ETFs to Buy to Protect Your Portfolio from a Potential Stock Market Crash
Investors may be getting spoiled. The S&P 500 (SNPINDEX: ^GSPC) has delivered double-digit gains for three consecutive years, with returns in two of those years topping 23%.
The idea of a stock
Retirees on Social Security Just Got Some Good News From Uncle Sam
If you watch the news on TV, you might feel like you see nothing but bad news. Network news organizations focus on negative stories because they drive ratings.
However, there's actually plenty of
3 Stocks That Turned $1,000 Into $1 Million (or More)
Most stocks dish out a decent enough performance. It's a rarity, however, for a relatively small investment to grow into a life-changing sum in the span of a single lifetime.
Every now and then
Why I'm Excited About Advanced Micro Devices Stock
Advanced Micro Devices (NASDAQ: AMD) shares have risen sharply in the last six months, but it's way too early to take profits. I continue to hold this stock, as AMD is well positioned to benefit
Sandisk Stock Is Up 1,500% in the Past Year Due to AI -- Is It Still a Buy? Wall Street Has a Surprising Answer for Investors.
Semiconductor company Sandisk (NASDAQ: SNDK) is one of the hottest artificial intelligence (AI) trades on the market. The stock led the S&P 500 higher in 2025, its price increasing more than
The AI Stock Wall Street Insiders Are Quietly Buying
2026 is shaping up to be a(nother) great year for artificial intelligence (AI) stocks. Data center infrastructure specialist Vertiv Holdings is already up 17.6%, and AI chipmaker Micron Technology
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026
John Walter Hanna Jr., President and CEO of CareDx (NASDAQ:CDNA), directly sold 19,480 shares in multiple open-market transactions on Jan. 21 and Jan. 22, 2026, for a total value of approximately
Could Royal Caribbean and Six Flags Be Lifelong Leisure Stocks for Your Portfolio?
People need diversions from the stress of their everyday lives. No wonder people take vacations and day trips.
But companies in the leisure industry often see their results fluctuate based on the
Harmony Biosciences Chief Financial Officer Sells Shares Again After Previous Exit From Company Equity
Sandip Kapadia, Chief Financial Officer of Harmony Biosciences (NASDAQ:HRMY), executed an open-market sale of 3,746 shares on Jan. 26, 2026, totaling approximately $139,171, according to a SEC Form
2 Unstoppable Stock-Split Growth Stocks That Could Soar 62% and 123% in 2026, According to Certain Wall Street Analysts
Stock splits have surged in popularity recently. This practice was commonplace in the 1990s, but fell out of fashion before experiencing a resurgence.
Investors are understandably intrigued by stock
Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026
On Jan. 22, 2026, Mo Qatanani, Chief Scientific Officer of Scholar Rock Holding Corporation (NASDAQ:SRRK), directly sold 14,898 shares in open-market transactions, totaling approximately $695,937
3 Questions Investors Should Answer Before Buying Beyond Meat Stock
Some on Wall Street claim that markets are efficient. That may be true over long periods, but investors are often highly irrational in the short term. Beyond Meat (NASDAQ: BYND) is a good example of
Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M
On Jan. 22, 2026, Fairmount Funds Management LLC, a Director at Cogent Biosciences (NASDAQ:COGT), reported the indirect sale of 3,500,000 shares for a total of apporximately $127.4 million
Should You Buy Nio Stock While It's Below $5 a Share?
The Chinese auto market is enormous. It comprised 30% of all global auto sales in 2025 and it positively dwarfs the next four largest markets -- the U.S. at 18% of all sales, India and Japan at
This Nearly 4%-Yielding Energy Stock Delivered Powerful Growth in 2025 With More to Come in 2026 and Beyond
Last year was a very strong year for Brookfield Renewable (NYSE: BEPC)(NYSE: BEP). The global renewable energy company delivered record financial results and made significant progress in securing
Enliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500k
Chief Scientific Officer Joseph P. Lyssikatos disposed of 20,000 shares of Enliven Therapeutics (NASDAQ:ELVN) in multiple open-market transactions on Jan. 20, 2026, for a total consideration of
Protagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover Taxes
Arturo Molina, Chief Medical Officer of Protagonist Therapeutics (NASDAQ:PTGX), directly sold 9,514 shares in an open-market transaction on Jan. 20, 2026, for an approximate value of $784,700
1 Underrated Reason Netflix's Growth Story Isn't Over
Netflix's (NASDAQ: NFLX) share prices have trended downward, for the most part, over the past six months. The company is dealing with several headwinds, including a recent earnings report that
3 AI Stocks to Buy in 2026 and Hold Forever
Finding artificial intelligence (AI) stocks with the intention of buying now and holding forever is a wise idea. There may be some companies that rise and fall, but I think these three have serious
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million
On Jan. 15 and Jan. 16, 2026, Joshua B Cohen, Co-Chief Executive Officer of Amylyx Pharmaceuticals (NASDAQ:AMLX), executed an exercise of 200,000 stock options and sold 138,167 shares in open-market


